| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 2.43e-05 | 2 | 99 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 2.43e-05 | 2 | 99 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 1.45e-04 | 4 | 99 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.41e-04 | 5 | 99 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 3.60e-04 | 6 | 99 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 5.03e-04 | 7 | 99 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 5.03e-04 | 7 | 99 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 5.03e-04 | 7 | 99 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.07e-03 | 10 | 99 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.07e-03 | 10 | 99 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.07e-03 | 10 | 99 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.07e-03 | 10 | 99 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.83e-03 | 13 | 99 | 2 | GO:0016713 | |
| Domain | HTH_Psq | 2.89e-05 | 12 | 97 | 3 | IPR007889 | |
| Domain | HTH_PSQ | 2.89e-05 | 12 | 97 | 3 | PS50960 | |
| Domain | zf-B_box | 3.62e-05 | 72 | 97 | 5 | PF00643 | |
| Domain | ZF_BBOX | 6.02e-05 | 80 | 97 | 5 | PS50119 | |
| Domain | Znf_B-box | 6.39e-05 | 81 | 97 | 5 | IPR000315 | |
| Domain | DUF3446 | 7.98e-05 | 3 | 97 | 2 | IPR021849 | |
| Domain | DUF3446 | 7.98e-05 | 3 | 97 | 2 | PF11928 | |
| Domain | ZF_RING_1 | 1.37e-04 | 291 | 97 | 8 | PS00518 | |
| Domain | ZF_RING_2 | 1.62e-04 | 298 | 97 | 8 | PS50089 | |
| Domain | Znf_RING_CS | 2.07e-04 | 163 | 97 | 6 | IPR017907 | |
| Domain | BBOX | 4.56e-04 | 69 | 97 | 4 | SM00336 | |
| Domain | Orgcat_transp/SVOP | 9.39e-04 | 9 | 97 | 2 | IPR004749 | |
| Domain | RING | 1.06e-03 | 305 | 97 | 7 | SM00184 | |
| Domain | SPRY | 1.09e-03 | 87 | 97 | 4 | SM00449 | |
| Domain | CENP-B_N | 1.17e-03 | 10 | 97 | 2 | PF04218 | |
| Domain | SPRY | 1.46e-03 | 94 | 97 | 4 | PF00622 | |
| Domain | SPRY_dom | 1.46e-03 | 94 | 97 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 1.52e-03 | 95 | 97 | 4 | IPR001870 | |
| Domain | B302_SPRY | 1.52e-03 | 95 | 97 | 4 | PS50188 | |
| Domain | Znf_RING | 1.55e-03 | 326 | 97 | 7 | IPR001841 | |
| Domain | CENPB | 1.70e-03 | 12 | 97 | 2 | SM00674 | |
| Domain | DDE_1 | 1.70e-03 | 12 | 97 | 2 | PF03184 | |
| Domain | DDE_SF_endonuclease_dom | 1.70e-03 | 12 | 97 | 2 | IPR004875 | |
| Domain | PRY | 1.98e-03 | 48 | 97 | 3 | SM00589 | |
| Domain | PRY | 1.98e-03 | 48 | 97 | 3 | IPR006574 | |
| Domain | HTH_CENPB | 2.01e-03 | 13 | 97 | 2 | PS51253 | |
| Domain | HTH_Tnp_Tc5 | 2.01e-03 | 13 | 97 | 2 | PF03221 | |
| Domain | HTH_CenpB_DNA-bd_dom | 2.01e-03 | 13 | 97 | 2 | IPR006600 | |
| Domain | ZINC_FINGER_C2H2_1 | TUT4 ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 2.31e-03 | 777 | 97 | 11 | PS00028 |
| Domain | Quinoprotein_ADH-like_supfam | 2.64e-03 | 53 | 97 | 3 | IPR011047 | |
| Domain | Bbox_C | 2.68e-03 | 15 | 97 | 2 | IPR003649 | |
| Domain | BBC | 2.68e-03 | 15 | 97 | 2 | SM00502 | |
| Domain | - | ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 2.76e-03 | 679 | 97 | 10 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF318 ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 2.78e-03 | 796 | 97 | 11 | IPR015880 |
| Domain | Znf_C2H2 | ZNF786 TRIM23 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 3.03e-03 | 805 | 97 | 11 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF318 ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 3.12e-03 | 808 | 97 | 11 | SM00355 |
| Domain | zf-C2H2 | ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 3.19e-03 | 693 | 97 | 10 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 3.23e-03 | 694 | 97 | 10 | IPR013087 |
| Domain | Apc4_WD40_dom | 4.77e-03 | 20 | 97 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.77e-03 | 20 | 97 | 2 | PF12894 | |
| Domain | Ank_2 | 5.28e-03 | 215 | 97 | 5 | PF12796 | |
| Domain | Butyrophylin | 5.78e-03 | 70 | 97 | 3 | IPR003879 | |
| Domain | - | 6.01e-03 | 71 | 97 | 3 | 4.10.45.10 | |
| Domain | - | 6.03e-03 | 222 | 97 | 5 | 1.25.10.10 | |
| Domain | zf-C3HC4 | 6.15e-03 | 223 | 97 | 5 | PF00097 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D9B ITPRIPL2 LPAR5 KIF26A MTG2 GEMIN5 KDM6B STK11IP BAHD1 ARHGEF10L JAK3 KMT2D ARVCF ZNF335 ZNF398 ZNF579 | 1.23e-07 | 1105 | 101 | 16 | 35748872 |
| Pubmed | Deletion of TECRL promotes skeletal muscle repair by up-regulating EGR2. | 8.35e-06 | 2 | 101 | 2 | 38753506 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21695374 | ||
| Pubmed | Molecular and functional characterization of organic cation/carnitine transporter family in mice. | 8.35e-06 | 2 | 101 | 2 | 11010964 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16469794 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21910182 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18274826 | ||
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 8.35e-06 | 2 | 101 | 2 | 8026587 | |
| Pubmed | Expression patterns of the organic cation/carnitine transporter family in adult murine brain. | 8.35e-06 | 2 | 101 | 2 | 17576045 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19814996 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19141711 | ||
| Pubmed | EGR3 as a potential susceptibility gene for schizophrenia in Korea. | 8.35e-06 | 2 | 101 | 2 | 20687139 | |
| Pubmed | Egr-2 and Egr-3 are negative regulators of T cell activation. | 8.35e-06 | 2 | 101 | 2 | 15834410 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 29314730 | ||
| Pubmed | Contribution of the IBD5 locus to Crohn's disease in the Swedish population. | 8.35e-06 | 2 | 101 | 2 | 17340776 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17387389 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23485457 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 32964310 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21606177 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16835882 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20020740 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19581171 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16519742 | ||
| Pubmed | Functional activity of L-carnitine transporters in human airway epithelial cells. | 8.35e-06 | 2 | 101 | 2 | 26607009 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16773684 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16333318 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21793125 | ||
| Pubmed | Organic cation/carnitine transporter family expression patterns in adult murine heart. | 8.35e-06 | 2 | 101 | 2 | 19233567 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23021953 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18641280 | ||
| Pubmed | SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. | 8.35e-06 | 2 | 101 | 2 | 19659785 | |
| Pubmed | Characterization of organic cation/carnitine transporter family in human sperm. | 8.35e-06 | 2 | 101 | 2 | 12788076 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28487311 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21706137 | ||
| Pubmed | Evidence for association of OCTN genes and IBD5 with ulcerative colitis. | 8.35e-06 | 2 | 101 | 2 | 16361305 | |
| Pubmed | Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity. | 8.35e-06 | 2 | 101 | 2 | 27856665 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16796743 | ||
| Pubmed | Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells. | 8.35e-06 | 2 | 101 | 2 | 32709717 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22325173 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23127916 | ||
| Pubmed | Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells. | 8.35e-06 | 2 | 101 | 2 | 36342511 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 31591905 | ||
| Pubmed | Early growth response transcriptional regulators are dispensable for macrophage differentiation. | 2.50e-05 | 3 | 101 | 2 | 17312150 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15685536 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15173177 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 2.50e-05 | 3 | 101 | 2 | 15145985 | |
| Pubmed | Functional variants of OCTN cation transporter genes are associated with Crohn disease. | 2.50e-05 | 3 | 101 | 2 | 15107849 | |
| Pubmed | Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. | 2.50e-05 | 3 | 101 | 2 | 16771961 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19412005 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16255050 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33011290 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32070725 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 35045301 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16441470 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19214536 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16344054 | ||
| Pubmed | OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. | 2.50e-05 | 3 | 101 | 2 | 18756601 | |
| Pubmed | Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. | 2.50e-05 | 3 | 101 | 2 | 16652416 | |
| Pubmed | Egr2 and 3 Inhibit T-bet-Mediated IFN-γ Production in T Cells. | 2.50e-05 | 3 | 101 | 2 | 28455436 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27911796 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 25979336 | ||
| Pubmed | Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. | 2.50e-05 | 3 | 101 | 2 | 15955786 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16373276 | ||
| Pubmed | Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies. | 2.50e-05 | 3 | 101 | 2 | 33124720 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17006998 | ||
| Pubmed | Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors. | 2.50e-05 | 3 | 101 | 2 | 19706684 | |
| Pubmed | Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. | 4.99e-05 | 4 | 101 | 2 | 17451203 | |
| Pubmed | Risk factors for perianal Crohn's disease: the role of genotype, phenotype, and ethnicity. | 4.99e-05 | 4 | 101 | 2 | 17509030 | |
| Pubmed | An amphioxus Krox gene: insights into vertebrate hindbrain evolution. | 4.99e-05 | 4 | 101 | 2 | 11180801 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 17786191 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 18668679 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 16437728 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 31334687 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 20506119 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 23567998 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 12535646 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11891986 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 16344053 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 4.99e-05 | 4 | 101 | 2 | 18065749 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 16670523 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 39337533 | ||
| Pubmed | Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome. | 8.30e-05 | 5 | 101 | 2 | 27667480 | |
| Pubmed | Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells. | 8.30e-05 | 5 | 101 | 2 | 29728568 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 17476680 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18162085 | ||
| Pubmed | Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. | 8.30e-05 | 5 | 101 | 2 | 18203138 | |
| Pubmed | HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. | 8.30e-05 | 5 | 101 | 2 | 11909874 | |
| Pubmed | Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity. | 8.30e-05 | 5 | 101 | 2 | 30012846 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 19169262 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18577768 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18698678 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 18715515 | ||
| Pubmed | Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. | 1.24e-04 | 6 | 101 | 2 | 18433468 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 17213842 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 9068972 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 37443284 | ||
| Pubmed | PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. | 1.24e-04 | 6 | 101 | 2 | 15523054 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 14560009 | ||
| Pubmed | No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. | 1.24e-04 | 6 | 101 | 2 | 20144677 | |
| Pubmed | 1.59e-04 | 529 | 101 | 8 | 14621295 | ||
| GeneFamily | Ring finger proteins | 1.11e-04 | 275 | 72 | 7 | 58 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF318 ZNF786 PRDM9 ZSCAN10 ZNF394 EGR2 EGR3 ZNF764 ZNF335 ZNF398 ZNF579 | 1.19e-04 | 718 | 72 | 11 | 28 |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 5.60e-04 | 95 | 72 | 4 | 59 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 1.19e-03 | 13 | 72 | 2 | 533 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 1.81e-03 | 16 | 72 | 2 | 66 | |
| GeneFamily | Ankyrin repeat domain containing | 2.78e-03 | 242 | 72 | 5 | 403 | |
| GeneFamily | Sterile alpha motif domain containing | 5.22e-03 | 88 | 72 | 3 | 760 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid-Microglia|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.49e-07 | 198 | 101 | 7 | 901cd39cb84f1907f2f5d27221979c854bd3b40e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Myeloid|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.49e-07 | 198 | 101 | 7 | cc292aa8518d5ef8940e2327f2f07d584a996d90 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.51e-06 | 170 | 101 | 6 | 9a18756e6721980d4b6c37bb52ddfe93ca79c5ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.68e-06 | 172 | 101 | 6 | 53dbfe1ac658fd94370cf8e745048cb67fda1daf | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 181 | 101 | 6 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 181 | 101 | 6 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 181 | 101 | 6 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.08e-06 | 185 | 101 | 6 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-06 | 185 | 101 | 6 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 4.21e-06 | 186 | 101 | 6 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 4.48e-06 | 188 | 101 | 6 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-06 | 189 | 101 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.62e-06 | 189 | 101 | 6 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 4.62e-06 | 189 | 101 | 6 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-06 | 189 | 101 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.21e-06 | 193 | 101 | 6 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-06 | 196 | 101 | 6 | 51c48944149a89b98011a50fe81ca6664d5f0d44 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-06 | 197 | 101 | 6 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.21e-06 | 199 | 101 | 6 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 2.51e-05 | 152 | 101 | 5 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-05 | 154 | 101 | 5 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.03e-05 | 158 | 101 | 5 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.03e-05 | 158 | 101 | 5 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.41e-05 | 162 | 101 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 3.41e-05 | 162 | 101 | 5 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-05 | 168 | 101 | 5 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-05 | 168 | 101 | 5 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.92e-05 | 175 | 101 | 5 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.06e-05 | 176 | 101 | 5 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.48e-05 | 179 | 101 | 5 | dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.48e-05 | 179 | 101 | 5 | 64672528f73ac0921f9c7df72e14ecbfac4d5270 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 179 | 101 | 5 | f3f9c7e575bc4d9d3bce649b90254182e8f6aaec | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 179 | 101 | 5 | 01e0b49e7f03ac9c3e6c34708ead300d27236b8b | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.48e-05 | 179 | 101 | 5 | fa0dd87111d399649cdea55f2e610ebc169e8a56 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.48e-05 | 179 | 101 | 5 | fae869fb0a91428481bf8a9c111dcc639e2b4278 | |
| ToppCell | 15-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 5.63e-05 | 180 | 101 | 5 | 99e2db9ad8e09fedc3542233553acece69f579f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-05 | 181 | 101 | 5 | 9dc0563453e24c9d1d975e2e0e1e272487e19908 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-05 | 181 | 101 | 5 | fe2f8b4bd8b09be8ba933529a16e1dca08740dab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-05 | 181 | 101 | 5 | 14c2dd946e89ba578711c2d25935b6b3d319b701 | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 5.78e-05 | 181 | 101 | 5 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-05 | 181 | 101 | 5 | c5843b89f3d362e236ff76c3279518a2fdfc1f75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-05 | 181 | 101 | 5 | fcefb5902416c004631f4f8dd5c8f99fe3bd90bc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-05 | 181 | 101 | 5 | a16079b1c832456b974d9d06dd1a3eda63ac1bce | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 182 | 101 | 5 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 182 | 101 | 5 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 182 | 101 | 5 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.09e-05 | 183 | 101 | 5 | b52d7683dc6652766e814ebe935c264ecd610c4b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.09e-05 | 183 | 101 | 5 | 1d77d8d8c8f78f43dd8864e76f294ee66d4942c2 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_reticulocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.09e-05 | 183 | 101 | 5 | 5470e5ac3439cfc96acd2202f6b1e386779a6637 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-05 | 184 | 101 | 5 | 371c1927ac06b77ff462a94cca6acb802f9724ff | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.25e-05 | 184 | 101 | 5 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 184 | 101 | 5 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-05 | 184 | 101 | 5 | fbac70333e4f028bfbdd9cc9401427caac9f0c47 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 6.25e-05 | 184 | 101 | 5 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-05 | 184 | 101 | 5 | dd6777a0cb49cd79fc439920c3c930a1e4681bb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-05 | 185 | 101 | 5 | 6b832b3e080dfadd21253ac45022192f4d3cb37b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.41e-05 | 185 | 101 | 5 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_reticulocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.41e-05 | 185 | 101 | 5 | 4a2c85e292d4cbce80e92992ded5d66a3aa446ee | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-05 | 186 | 101 | 5 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-05 | 186 | 101 | 5 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.57e-05 | 186 | 101 | 5 | 34ed60e846fd83fab3e28dc9e278bcc4b092a9f0 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_reticulocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.57e-05 | 186 | 101 | 5 | bf8ca7135c05d772aa3f5960b419a13aef3936ae | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.57e-05 | 186 | 101 | 5 | 40acd9b4e9b3c1d1527bd4ba17ae830ff18d6e9d | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 6.74e-05 | 187 | 101 | 5 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.74e-05 | 187 | 101 | 5 | c0965293f08d3e49000871777a5b26d81a4af203 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.91e-05 | 188 | 101 | 5 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.91e-05 | 188 | 101 | 5 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.91e-05 | 188 | 101 | 5 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | a273fc119baebc11020009c923beafeebb6428c9 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 7.27e-05 | 190 | 101 | 5 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-05 | 192 | 101 | 5 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.21e-05 | 195 | 101 | 5 | 4759018a7c016cb2e3df5696f1e5f912c7c9ee17 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-GABAergic_neurons|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.21e-05 | 195 | 101 | 5 | efdea22118d5be46c5abfe8e3fbe39503390665d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-05 | 196 | 101 | 5 | 0aae78e73d53416d857bdf21f595a0a0a0ba7944 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-05 | 196 | 101 | 5 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 197 | 101 | 5 | d8f99a9f2367c8bc9308b0c64d0226875262927a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-05 | 197 | 101 | 5 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 197 | 101 | 5 | 1ffbbe44db0fd3ebd91ad16ab0b91153de5d7c6d | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 8.83e-05 | 198 | 101 | 5 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 8.83e-05 | 198 | 101 | 5 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 198 | 101 | 5 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.04e-05 | 199 | 101 | 5 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | 8d0eb13a391a2ac1b4f332290c2d00a7fb42bddc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | e6853b2c0ef6549d5554754c5d5f65825b66025b | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 9.04e-05 | 199 | 101 | 5 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-05 | 200 | 101 | 5 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-05 | 200 | 101 | 5 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-05 | 200 | 101 | 5 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-T/NK_proliferative|Bac-SEP / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | a09b4e07b273880e94032b939ab191caaf6d656e | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-05 | 200 | 101 | 5 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.25e-05 | 200 | 101 | 5 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| Drug | 5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA | 2.57e-06 | 195 | 101 | 8 | 898_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.40e-05 | 192 | 101 | 7 | 3858_DN | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 2770_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 1680_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A | 2.92e-05 | 198 | 101 | 7 | 2006_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 6982_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A | 3.01e-05 | 199 | 101 | 7 | 1375_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 5789_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 6968_DN | |
| Disease | carnitine measurement | 1.04e-04 | 76 | 94 | 4 | EFO_0010469 | |
| Disease | Coxsackievirus Infections | 1.49e-04 | 6 | 94 | 2 | C0010246 | |
| Disease | Myocarditis | 1.49e-04 | 6 | 94 | 2 | C0027059 | |
| Disease | Carditis | 1.49e-04 | 6 | 94 | 2 | C0869523 | |
| Disease | acetylcarnitine measurement | 2.78e-04 | 8 | 94 | 2 | EFO_0021038 | |
| Disease | butyrylcarnitine measurement | 2.78e-04 | 8 | 94 | 2 | EFO_0020010 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 3.56e-04 | 9 | 94 | 2 | EFO_0800549 | |
| Disease | neutrophil count | TRIM58 IQSEC2 WDR27 RIPOR3 ACVRL1 KDM6B ZNF786 ARVCF SLC22A4 SLC22A5 ZNF398 ARHGAP45 NUP160 | 4.35e-04 | 1382 | 94 | 13 | EFO_0004833 |
| Disease | lignoceroylcarnitine (C24) measurement | 5.42e-04 | 11 | 94 | 2 | EFO_0800541 | |
| Disease | tryptophan betaine measurement | 6.49e-04 | 12 | 94 | 2 | EFO_0021017 | |
| Disease | hexanoylcarnitine measurement | 6.49e-04 | 12 | 94 | 2 | EFO_0021040 | |
| Disease | lymphocyte count | TRIM58 LCORL WDR27 RIPOR3 ARTN ACVRL1 ARVCF EGR2 SLC22A4 SLC22A5 CYP4F3 ARHGAP45 NUP160 | 7.45e-04 | 1464 | 94 | 13 | EFO_0004587 |
| Disease | homostachydrine measurement | 7.65e-04 | 13 | 94 | 2 | EFO_0021164 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 7.65e-04 | 13 | 94 | 2 | EFO_0800547 | |
| Disease | cerotoylcarnitine (C26) measurement | 7.65e-04 | 13 | 94 | 2 | EFO_0800542 | |
| Disease | oleoylcarnitine measurement | 1.66e-03 | 19 | 94 | 2 | EFO_0021043 | |
| Disease | neuroticism measurement | ANKRD10 FAM120AOS ACVRL1 BTN2A1 ARHGEF10L STAB1 ARVCF NUP160 SEMA3E | 2.47e-03 | 909 | 94 | 9 | EFO_0007660 |
| Disease | stearoylcarnitine measurement | 2.65e-03 | 24 | 94 | 2 | EFO_0021045 | |
| Disease | Cardiac Arrhythmia | 2.87e-03 | 25 | 94 | 2 | C0003811 | |
| Disease | L lactate dehydrogenase measurement | 3.10e-03 | 26 | 94 | 2 | EFO_0004808 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRSRPCARDAHRKEI | 1221 | Q9HCE6 | |
| VEHRFARRCTPEPQR | 536 | Q8TDY4 | |
| SLRFPLHRACRDGDL | 21 | Q9NXR5 | |
| HPRAEVRRRACGALR | 411 | O00192 | |
| YARRRVSLGIDICHP | 46 | Q9H568 | |
| FLCHEFLRGNPRVTR | 376 | Q96SM3 | |
| NLHRELCRGRPTEFV | 71 | P37023 | |
| EVFRLGRPRLAAHCA | 871 | Q96C12 | |
| GEAFHCRLQGPRRVD | 151 | Q5T7M4 | |
| DRDPGDRLIRHRACA | 1066 | Q6PL18 | |
| EDAHLRPRAGAARAR | 81 | Q8IUH2 | |
| CGATRERAHTRRFCP | 96 | P60323 | |
| VEHCDFGPARRLRSR | 101 | Q6ZMN7 | |
| GCDRRFSRSDELTRH | 346 | P11161 | |
| PSGCLRDFLQRHRAR | 906 | P52333 | |
| HFCRDGRVLLGSRAL | 486 | Q14296 | |
| SHRRFEGCTPRKCGR | 96 | Q6PK18 | |
| DLLEARRPRAHECLG | 141 | Q92619 | |
| RRPRAHECLGEALRV | 146 | Q92619 | |
| RGHLCRTRPTDLVFV | 31 | P21941 | |
| RLDRHGFVSREFCRT | 106 | Q16082 | |
| AARVHRPSRCRYRDL | 156 | Q9H1C0 | |
| RRDFCGRPRFLHIRR | 321 | Q9Y5R4 | |
| HFCLGRRRLHLFGRD | 336 | Q9HCE5 | |
| GLGHRSDELVRFRFC | 136 | Q5T4W7 | |
| GAARRPDEHGRCLRL | 261 | Q6ZVZ8 | |
| PGCLECRDFRLRAAH | 576 | Q5JU85 | |
| SPRCAAERRGFRREL | 26 | Q8N3X6 | |
| HRRACKDSVGRRPRE | 986 | O15054 | |
| SCPHRLREHLERGRG | 181 | P55899 | |
| GVAAPRRLRRAADHD | 211 | Q9UHG2 | |
| DCAARAPVRAEAVRR | 461 | Q32MK0 | |
| IRGAECTERIHRLFG | 91 | Q96MW5 | |
| SSCEEGRARRPPHLR | 741 | Q9ULI4 | |
| LRHCARKLDPRREGA | 466 | Q9UI32 | |
| GCPIRVEHDRRRRQF | 16 | Q8N6N6 | |
| RECGRGFRDKSHLLR | 751 | Q9NQV7 | |
| RRDVTRRCCLRPGHY | 486 | Q6ZSI9 | |
| FRRRHGVVSCSGVAR | 126 | P07199 | |
| RPDDAIELFNRCRGH | 221 | O75319 | |
| GCDRRFSRSDELTRH | 281 | Q06889 | |
| SRAGDPHRSRDRDRA | 146 | Q8TBE0 | |
| PDGQRFRRACRLVHD | 251 | P78329 | |
| DRRSVRRCPFRHLGE | 346 | Q7KYR7 | |
| CRLHQAPTARGAVRF | 91 | P19235 | |
| PDGQRFRRACRLVHD | 251 | Q08477 | |
| RRCAIHDIRFSPDSR | 1776 | Q05BV3 | |
| HERRPVLGCRELVFR | 341 | Q86Y56 | |
| NHCRDASLISRFRPR | 156 | Q1W209 | |
| RCIAERAFLRHLEGG | 246 | P08397 | |
| CRRFKLTDFGHTRPR | 196 | P0C263 | |
| LRDGREVPHSCSRYR | 71 | Q9H015 | |
| LRDGREVPHSCRRYR | 71 | O76082 | |
| PFADAFCVDVRGRRH | 231 | Q3MIP1 | |
| LRHRSRCATPPRGDF | 6 | O43482 | |
| LYRLATGCHRRDELP | 131 | Q8N0Z8 | |
| TGCHRRDELPVFERN | 136 | Q8N0Z8 | |
| ERCGLRSVDHRLRLF | 781 | Q8N1F8 | |
| PRDARHCRAFLEELL | 891 | Q8N1F8 | |
| QPLCARCRDETHRAR | 121 | Q6ZRF8 | |
| RFRDRHGIALKAVCR | 126 | Q17RP2 | |
| RLPCVRLHAFRDARE | 161 | Q6IEE7 | |
| LCPGTHYRARVEVRL | 1046 | Q9UFD9 | |
| RCRDEVHFDPRQRGL | 426 | O15197 | |
| PKRSRRDFGLDCDEH | 261 | O14793 | |
| TRCPQRRHGRATFCA | 71 | Q5T036 | |
| PRVHVRDEGEFTCRA | 316 | Q9NYZ4 | |
| RFCCHDGPRRLDQSR | 91 | B8ZZ34 | |
| GLGSAFLRHIERCRF | 291 | Q9H4K7 | |
| RHCRSYDRRALLPAV | 461 | Q9NWF9 | |
| PRVRFANDDRHRLAC | 176 | Q9H1Z4 | |
| HREARGPSFRICVDF | 76 | Q08648 | |
| AERERPRHFREFTVC | 51 | Q12769 | |
| RTLCLGGAHIDFRAR | 231 | Q9Y566 | |
| RATFRLPRDERLDGH | 291 | Q66K14 | |
| RALPDARARGHDVRF | 211 | Q8NET6 | |
| ELRDRAPGFRTSDRH | 406 | Q5SXH7 | |
| PICSHRERRDAGRRT | 311 | Q8TCW7 | |
| RLDPARRDFCRESAQ | 171 | Q53GI3 | |
| GSRRRDSDRRPFVCS | 456 | Q96SZ4 | |
| RAFARCPPSRAARES | 161 | Q96MK2 | |
| RRAHASERPFRCAQC | 446 | Q8TD17 | |
| REEPLCNFRGHRGRL | 671 | Q8TEQ6 | |
| VTEPECREGFHRRAR | 111 | P01185 | |
| LREHCRRAAEACARP | 46 | Q3KQV9 | |
| ARCDHFETRPLRLNT | 1871 | Q9NY15 | |
| CRESREHRLHRVLPA | 121 | Q9Y577 | |
| CHRSLILDDRGLRGF | 131 | Q9C026 | |
| CGRRFAADVLERHGP | 21 | Q5TFG8 | |
| RHQRIHRPERPFACG | 721 | Q8N393 | |
| FHLESPRSERGRGRC | 156 | O15041 | |
| DDLRPENHARRSFVC | 311 | Q9UHJ3 | |
| PCIYDGKESARRLRH | 166 | Q5HYJ1 | |
| RTLRCERHFEGHPTR | 741 | A2RRH5 | |
| HGRAIRCPFDRQVTD | 66 | P36406 | |
| HDTRDFRDPRDLRCF | 1346 | Q5TAX3 | |
| SCPDEHDTLPRRRGR | 426 | Q9H4Z2 | |
| CPECGKGFRRRAHLR | 386 | Q8NAF0 | |
| HFCVSTPERRRLSDR | 156 | Q5VUA4 | |
| STERHIRDRLGRKPC | 51 | O60384 | |
| PGARRCARHGEDLSR | 91 | Q8NG06 | |
| RGERPHRCLECGRAF | 226 | Q96H86 | |
| CGEPSLHGQRELRRF | 71 | O14686 | |
| CAAGHRAELLRFPER | 31 | P23919 |